Emily C. Gurley
- Molecular Biology top 10%
- Epidemiology top 5%
- Surgery top 5%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Phillip B. HylemonHuiping ZhouWilliam M. PandakZ.R. VlahcevicRunping LiuXiaojiaoyang LiElaine StuderGuangji Wang
- Topics
- Liver Disease Diagnosis and Treatment (19 papers)Drug Transport and Resistance Mechanisms (14 papers)Cholesterol and Lipid Metabolism (8 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Emily C. Gurley
44 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.2k
- Epidemiology 862
- Surgery 786
- Oncology 722
- Cancer Research 463
Countries citing papers authored by Emily C. Gurley
This map shows the geographic impact of Emily C. Gurley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily C. Gurley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily C. Gurley more than expected).
Fields of papers citing papers by Emily C. Gurley
This network shows the impact of papers produced by Emily C. Gurley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily C. Gurley. The network helps show where Emily C. Gurley may publish in the future.
Co-authorship network of co-authors of Emily C. Gurley
This figure shows the co-authorship network connecting the top 25 collaborators of Emily C. Gurley. A scholar is included among the top collaborators of Emily C. Gurley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily C. Gurley. Emily C. Gurley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 13 | |
| 5 | 78 | |
| 6 | 1 | |
| 7 | 21 | |
| 8 | 107 | |
| 9 | 82 | |
| 10 | 180 | |
| 11 | 127 | |
| 12 | 8 | |
| 13 | 92 | |
| 14 | 21 | |
| 15 | 70 | |
| 16 | 60 | |
| 17 | 139 | |
| 18 | 119 | |
| 19 | 67 | |
| 20 | 82 |
About Emily C. Gurley
Emily C. Gurley is a scholar working on Virology, Hepatology and Pharmacology, having authored 44 papers that have together received 2.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Drug Transport and Resistance Mechanisms (14 papers) and Cholesterol and Lipid Metabolism (8 papers). The work is most often cited by research in Hepatology (406 citations), Pharmacology (330 citations) and Cancer Research (463 citations). Emily C. Gurley has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Phillip B. Hylemon, Huiping Zhou, William M. Pandak, Z.R. Vlahcevic, Runping Liu, Xiaojiaoyang Li, Elaine Studer, Guangji Wang, R. Todd Stravitz and Xiaoxuan Zhang. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.